Company / R&D per Share
Baxter International R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.02
FY2025
5-year range
$0.87 / $1.17
FY2021-FY2025
Trend
-12.9%
vs FY2024
Sector context
#72 of 108
Health Care
What the data says
At $1.02, Baxter International's r&d per share ranks #72 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.87 in FY2022 to $1.19 in FY2018.
Based on SEC 10-K filings.
1.02 in FY2025 with a 5-year CAGR of +1.3%.
Remained stable around $1.02 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +5.4%
- 5-Year CAGR
- +1.3%
- 10-Year CAGR
- -
Sector benchmark
#72 of 108 in Health CareTop 67% of 108This company $1.02 Sector average $2.07
▼
-50.7% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 12.9% year-over-year.
- Ranks #72 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2018.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.02 | -12.9% |
| FY2024 | $1.17 | +14.8% |
| FY2023 | $1.02 | +17.2% |
| FY2022 | $0.87 | -14.9% |
| FY2021 | $1.02 | +7.2% |
| FY2020 | $0.95 | -13.9% |
| FY2019 | $1.11 | -6.6% |
| FY2018 | $1.19 | +6.0% |
| FY2017 | $1.12 | +0.5% |
| FY2016 | $1.12 | +1.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026